Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus
Hormone and Metabolic Research · 01.03.2024 · 56 (03) · 206-213
DOI: 10.1055/a-2198-7207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.03.2024. Verfasst von Aslak Nykjær Pedersen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Diabetes Insipidus, Neurogenic, Hyponatremia, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Central diabetes insipidus is a rare disorder characterized by a deficiency of vasopressin. The first line drug to treat this disorder is a synthetic analogue of vasopressin, desmopressin.The primary aim of this retrospective register study was to compare desmopressin dose requirements in patients with acquired and congenital DI, and secondly to assess the influence of BMI on dose requirement and risk of hyponatremia with different drug administrations. We included all patients with suspected DI attending the endocrine department at Rigshospitalet, Copenhagen, Denmark in 2022. We identified 222 patients who were included whereof 130/222 (58.6%) were females and median age was 53 years (IQR 35 to 63). The etiology included 7/222 (3.2%) congenital and 215/222 (96.8%) acquired. After converting nasal and sublingual doses to equivalent oral doses, the median daily dose requirement was 600 μg in patients with congenital etiology compared to 200 μg in patients with acquired etiology (p=0.005). We found no association between BMI and desmopressin dose requirements (p=0.6). During the past 12 months, 66/215 (30.7%) had sodium levels
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Endocrinology, Zealand University Hospital Koge, Koge, Denmark.
ORCID-Profile: Aslak Nykjær Pedersen
Zitieren
APA
Pedersen, A. N., Andreassen, M., Rasmussen, A. K., & Krogh, J. (2024). Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus. Hormone and Metabolic Research, 56(03), 206-213. https://doi.org/10.1055/a-2198-7207
Vancouver
Pedersen AN, Andreassen M, Rasmussen AK, Krogh J. Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus. Hormone and Metabolic Research. 2024;56(03):206-213. doi:10.1055/a-2198-7207
BibTeX
@article{Pedersen2024,
author = {Pedersen, Aslak Nykjær and Andreassen, Mikkel and Rasmussen, Aase Krogh and Krogh, Jesper},
title = {Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {03},
pages = {206--213},
doi = {10.1055/a-2198-7207}
}
EUVIMED